143 related articles for article (PubMed ID: 28979774)
21. Evaluation of the cisplatin nephrotoxicity using the urinary neutrophil gelatinase-associated lipocalin (NGAL) in patients with head and neck cancer.
Peres LA; da Cunha AD; Assumpção RA; Schäfer A; da Silva AL; Gaspar AD; Scarpari DF; Alves JB; Girelli Neto R; de Oliveira TF
J Bras Nefrol; 2014; 36(3):280-8. PubMed ID: 25317609
[TBL] [Abstract][Full Text] [Related]
22. [Acute kidney injury in children].
Amira-Peco-Antić ; Paripović D
Srp Arh Celok Lek; 2014; 142(5-6):371-7. PubMed ID: 25033598
[TBL] [Abstract][Full Text] [Related]
23. Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
Succar L; Pianta TJ; Davidson T; Pickering JW; Endre ZH
Kidney Int; 2017 Sep; 92(3):680-692. PubMed ID: 28476556
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding.
Soni H; Kaminski D; Gangaraju R; Adebiyi A
Ren Fail; 2018 Nov; 40(1):314-322. PubMed ID: 29619879
[TBL] [Abstract][Full Text] [Related]
25. Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury.
Won AJ; Kim S; Kim YG; Kim KB; Choi WS; Kacew S; Kim KS; Jung JH; Lee BM; Kim S; Kim HS
Mol Biosyst; 2016 Jan; 12(1):133-44. PubMed ID: 26566257
[TBL] [Abstract][Full Text] [Related]
26. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
[TBL] [Abstract][Full Text] [Related]
27. Kidney biomarkers in cirrhosis.
Francoz C; Nadim MK; Durand F
J Hepatol; 2016 Oct; 65(4):809-824. PubMed ID: 27238754
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy.
Kos FT; Sendur MA; Aksoy S; Celik HT; Sezer S; Civelek B; Yaman S; Zengin N
Asian Pac J Cancer Prev; 2013; 14(2):1111-4. PubMed ID: 23621196
[TBL] [Abstract][Full Text] [Related]
29. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
Sinna MM; Altaf FMN; Mosa OF
Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
[TBL] [Abstract][Full Text] [Related]
30. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
31. Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.
Oh SM; Park G; Lee SH; Seo CS; Shin HK; Oh DS
BMC Complement Altern Med; 2017 Dec; 17(1):544. PubMed ID: 29258482
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
33. Urinary, Plasma, and Serum Biomarkers' Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis.
Ho J; Tangri N; Komenda P; Kaushal A; Sood M; Brar R; Gill K; Walker S; MacDonald K; Hiebert BM; Arora RC; Rigatto C
Am J Kidney Dis; 2015 Dec; 66(6):993-1005. PubMed ID: 26253993
[TBL] [Abstract][Full Text] [Related]
34. Acute Kidney Injury Induced by
Albuquerque PLMM; da Silva Junior GB; Meneses GC; Martins AMC; Lima DB; Raubenheimer J; Fathima S; Buckley N; Daher EF
Toxins (Basel); 2019 Mar; 11(3):. PubMed ID: 30841537
[TBL] [Abstract][Full Text] [Related]
35. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
Hosohata K; Ando H; Fujimura A
J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside.
Uchino H; Fujishima J; Fukuoka K; Iwakiri T; Kamikuri A; Maeda H; Nakama K
J Toxicol Sci; 2017; 42(5):629-640. PubMed ID: 28904298
[TBL] [Abstract][Full Text] [Related]
37. Potential nephroprotective effects of the Chinese herb Angelica sinensis against cisplatin tubulotoxicity.
Bunel V; Antoine MH; Nortier J; Duez P; Stévigny C
Pharm Biol; 2015 Jul; 53(7):985-94. PubMed ID: 25495691
[TBL] [Abstract][Full Text] [Related]
38. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
[TBL] [Abstract][Full Text] [Related]
39. Serum Neutrophil Gelatinase-Associated Lipocalin and Urinary Kidney Injury Molecule-1 as Potential Biomarkers of Subclinical Nephrotoxicity After Gadolinium-Based and Iodinated-Based Contrast Media Exposure in Pediatric Patients with Normal Kidney Function.
Spasojević-Dimitrijeva B; Kotur-Stevuljević J; Đukić M; Paripović D; Miloševski-Lomić G; Spasojević-Kalimanovska V; Pavićević P; Mitrović J; Kostić M
Med Sci Monit; 2017 Sep; 23():4299-4305. PubMed ID: 28874655
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
